comparemela.com

Latest Breaking News On - ஆரோக்கியம் அமைச்சகம் கூட்டு செயலாளர் லாவ் அகர்வால் - Page 4 : comparemela.com

Moderna s single-dose Covid-19 vaccine in India likely in 2022; Pfizer ready with 5 cr doses for 2021

Moderna s single-dose Covid-19 vaccine in India likely in 2022; Pfizer ready with 5 cr doses for 202 Moderna s single-dose Covid-19 vaccine in India likely in 2022; Pfizer ready with 5 cr doses for 2021 Moderna is in talks with Cipla and other Indian pharma firms to launch its single-dose Covid-19 vaccine in India by next year. Meanwhile, Pfizer has reportedly indicated that it can provide 5 crore doses of its vaccine this year itself. advertisement UPDATED: May 25, 2021 22:12 IST Two rounds of high-level meetings chaired by the Cabinet Secretary were held last week on the availability of Covid-19 vaccines in the global as well as domestic markets. (Photo: PTI)

Moderna s single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021

›Moderna s single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021 Moderna s single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021 SECTIONS Moderna s single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021PTI Last Updated: May 25, 2021, 08:40 PM IST Share Synopsis Two rounds of high-level meetings chaired by the Cabinet Secretary were held last week on the availability of vaccines in the global as well as domestic markets as it was felt that there is an urgent need to procure the jabs at a time the country is reeling under an unprecedented second wave of COVID-19 and a widening gap between supply and requirement.

Moderna, Pfizer COVID-19 Vaccines Likely In India Next Year: Report

Moderna has said doesn t have surplus COVID-19 vaccines to share in 2021. (File) New Delhi: Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday. While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future, the sources privy to discussions added.

Several states extend Covid curbs; six states report high mortality: Top developments | India News

NEW DELHI: As India reels under the second wave of the Covid-19 pandemic, several states are extending the curbs to evade the surge in daily Covid cases and safeguard the lives of their people. India s Covid curve continued to remain below the three lakh mark for the sixth consecutive day, with 2.57 lakh new cases recorded in a single day, the Union health ministry said on Saturday. Here are the top developments of the day: Several states extend Covid curbs Tamil Nadu joined Uttar Pradesh and Northeast states to extend lockdown with a large party of the country already under Covid-induced restrictions till month-end.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.